Free Trial
NASDAQ:CERS

Cerus (CERS) Stock Price, News & Analysis

Cerus logo
$1.48 +0.02 (+1.03%)
As of 03:30 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Cerus Stock (NASDAQ:CERS)

Key Stats

Today's Range
$1.46
$1.51
50-Day Range
$1.23
$1.56
52-Week Range
$1.12
$2.54
Volume
454,438 shs
Average Volume
1.33 million shs
Market Capitalization
$281.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.50
Consensus Rating
Buy

Company Overview

Cerus Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
64th Percentile Overall Score

CERS MarketRank™: 

Cerus scored higher than 64% of companies evaluated by MarketBeat, and ranked 340th out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cerus has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Cerus has received no research coverage in the past 90 days.

  • Read more about Cerus' stock forecast and price target.
  • Earnings Growth

    Earnings for Cerus are expected to grow in the coming year, from ($0.08) to ($0.06) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cerus is -14.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cerus is -14.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Cerus has a P/B Ratio of 4.76. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Cerus' valuation and earnings.
  • Percentage of Shares Shorted

    3.72% of the float of Cerus has been sold short.
  • Short Interest Ratio / Days to Cover

    Cerus has a short interest ratio ("days to cover") of 5.5.
  • Change versus previous month

    Short interest in Cerus has recently decreased by 25.66%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Cerus does not currently pay a dividend.

  • Dividend Growth

    Cerus does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.72% of the float of Cerus has been sold short.
  • Short Interest Ratio / Days to Cover

    Cerus has a short interest ratio ("days to cover") of 5.5.
  • Change versus previous month

    Short interest in Cerus has recently decreased by 25.66%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Cerus has a news sentiment score of 1.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Cerus this week, compared to 2 articles on an average week.
  • Search Interest

    Only 2 people have searched for CERS on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Cerus to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cerus insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.40% of the stock of Cerus is held by insiders.

  • Percentage Held by Institutions

    78.37% of the stock of Cerus is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Cerus' insider trading history.
Receive CERS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cerus and its competitors with MarketBeat's FREE daily newsletter.

CERS Stock News Headlines

Banks aren’t ready for this altcoin—are you?
Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly positioned to fill it…
Cerus Corporation Celebrates World Blood Donor Day 2025
See More Headlines

CERS Stock Analysis - Frequently Asked Questions

Cerus' stock was trading at $1.54 at the start of the year. Since then, CERS shares have decreased by 4.2% and is now trading at $1.4750.

Cerus Corporation (NASDAQ:CERS) released its quarterly earnings results on Thursday, May, 1st. The biotechnology company reported ($0.04) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.05) by $0.01. The biotechnology company earned $43.24 million during the quarter, compared to the consensus estimate of $47.44 million. Cerus had a negative net margin of 10.23% and a negative trailing twelve-month return on equity of 34.81%.
Read the conference call transcript
.

Shares of CERS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cerus investors own include American Water Works (AWK), Waste Connections (WCN), DiamondRock Hospitality (DRH), The RMR Group (RMR), Voyager Therapeutics (VYGR), AU Optronics (AUOTY) and iShares Micro-Cap ETF (IWC).

Company Calendar

Last Earnings
5/01/2025
Today
7/09/2025
Next Earnings (Estimated)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:CERS
CIK
1020214
Employees
290
Year Founded
1991

Price Target and Rating

High Price Target
$4.00
Low Price Target
$3.00
Potential Upside/Downside
+137.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$20.92 million
Pretax Margin
-10.15%

Debt

Sales & Book Value

Annual Sales
$180.27 million
Price / Cash Flow
N/A
Book Value
$0.31 per share
Price / Book
4.76

Miscellaneous

Free Float
184,661,000
Market Cap
$281.96 million
Optionable
Optionable
Beta
1.56

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:CERS) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners